Metabolic signatures in post-myocardial infarction heart failure, including insights into prediction, intervention,...

Area of Science:

• Cardiology
• Metabolomics
• Biochemistry

Background:

• Heart failure (HF) is a common and serious complication following myocardial infarction (MI).
• Patients with post-MI HF face a poor prognosis, necessitating early risk identification.
• Adverse cardiac remodeling in post-MI HF is linked to metabolic alterations due to ischemia.

Purpose of the Study:

• To review metabolic signatures of post-MI HF for non-invasive biomarker potential.
• To explore the role of metabolism in the pathophysiology of post-MI HF.
• To discuss metabolites as potential therapeutic targets and prognostic biomarkers for post-MI HF.

Main Methods:

• Literature review focusing on metabolic changes in post-MI HF.
• Analysis of risk factors influencing metabolic pathways (genetics, diet, obesity).
• Exploration of metabolite roles in cardiac remodeling and disease progression.

Main Results:

• Metabolic signatures can serve as non-invasive biomarkers for early detection in at-risk populations.
• Metabolism is integral to the pathophysiology of post-MI HF.
• Metabolites show promise as novel therapeutic targets and prognostic indicators.

Conclusions:

• Metabolic profiling offers valuable insights for preventing and treating post-MI HF.
• Early identification of high-risk individuals via metabolic biomarkers is crucial.
• Targeting metabolic pathways may improve outcomes for patients with post-MI HF.